GLAUKOS CorpGKOS

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$154.88
Market cap
$9.1B
P/E
—
Revenue (TTM)
$612.8M
Net income
-$188.0M
Dividend yield
—
1-year total return
90.1%
Net margin
-30.7%
Revenue growth
41.5%
Debt / equity
—

What GLAUKOS Corp does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$225.0M$294.0M$282.9M$314.7M$383.5M$507.4M
Net income-$120.3M-$49.6M-$99.2M-$134.7M-$146.4M-$187.7M
Free cash flow-$29.9M-$23.1M-$63.3M-$78.0M-$67.6M-$22.5M

More on GKOS.

Figures from GLAUKOS Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.